IGF-1R
Use this icon in our BioRender software along with 1000s of others. Create your next scientific figure in minutes!
SIGN UP FREE[{"image":"https://icons.biorender.com/w75xh75/60a54c035feb3b00281478b9/igf-1r.png","waterMarkImage":"https://icons.biorender.com/w550xh620/60a54c035feb3b00281478b9/igf-1r.png"},{"image":"https://icons.biorender.com/w75xh75/60a54c035feb3b00281478b8/igf-1r.png","waterMarkImage":"https://icons.biorender.com/w550xh620/60a54c035feb3b00281478b8/igf-1r.png"},{"image":"https://icons.biorender.com/w75xh75/60a54c035feb3b00281478b7/igf-1r.png","waterMarkImage":"https://icons.biorender.com/w550xh620/60a54c035feb3b00281478b7/igf-1r.png"},{"image":"https://icons.biorender.com/w75xh75/60a54c035feb3b00281478b6/igf-1r.png","waterMarkImage":"https://icons.biorender.com/w550xh620/60a54c035feb3b00281478b6/igf-1r.png"},{"image":"https://icons.biorender.com/w75xh75/60a54c035feb3b00281478b5/igf-1r.png","waterMarkImage":"https://icons.biorender.com/w550xh620/60a54c035feb3b00281478b5/igf-1r.png"},{"image":"https://icons.biorender.com/w75xh75/60a54c035feb3b00281478b4/igf-1r.png","waterMarkImage":"https://icons.biorender.com/w550xh620/60a54c035feb3b00281478b4/igf-1r.png"},{"image":"https://icons.biorender.com/w75xh75/60a54c035feb3b00281478b3/igf-1r.png","waterMarkImage":"https://icons.biorender.com/w550xh620/60a54c035feb3b00281478b3/igf-1r.png"},{"image":"https://icons.biorender.com/w75xh75/60a54c035feb3b00281478b2/igf-1r.png","waterMarkImage":"https://icons.biorender.com/w550xh620/60a54c035feb3b00281478b2/igf-1r.png"},{"image":"https://icons.biorender.com/w75xh75/60a54c035feb3b00281478b1/igf-1r.png","waterMarkImage":"https://icons.biorender.com/w550xh620/60a54c035feb3b00281478b1/igf-1r.png"},{"image":"https://icons.biorender.com/w75xh75/60a54c035feb3b00281478b0/igf-1r.png","waterMarkImage":"https://icons.biorender.com/w550xh620/60a54c035feb3b00281478b0/igf-1r.png"},{"image":"https://icons.biorender.com/w75xh75/60a54c035feb3b00281478af/igf-1r.png","waterMarkImage":"https://icons.biorender.com/w550xh620/60a54c035feb3b00281478af/igf-1r.png"},{"image":"https://icons.biorender.com/w75xh75/60a54c035feb3b00281478ae/igf-1r.png","waterMarkImage":"https://icons.biorender.com/w550xh620/60a54c035feb3b00281478ae/igf-1r.png"},{"image":"https://icons.biorender.com/w75xh75/60a54c035feb3b00281478ad/igf-1r.png","waterMarkImage":"https://icons.biorender.com/w550xh620/60a54c035feb3b00281478ad/igf-1r.png"},{"image":"https://icons.biorender.com/w75xh75/60a54c035feb3b00281478ac/igf-1r.png","waterMarkImage":"https://icons.biorender.com/w550xh620/60a54c035feb3b00281478ac/igf-1r.png"},{"image":"https://icons.biorender.com/w75xh75/60a54c035feb3b00281478ab/igf-1r.png","waterMarkImage":"https://icons.biorender.com/w550xh620/60a54c035feb3b00281478ab/igf-1r.png"},{"image":"https://icons.biorender.com/w75xh75/60a54c035feb3b00281478aa/igf-1r.png","waterMarkImage":"https://icons.biorender.com/w550xh620/60a54c035feb3b00281478aa/igf-1r.png"},{"image":"https://icons.biorender.com/w75xh75/60a54c035feb3b00281478a9/igf-1r.png","waterMarkImage":"https://icons.biorender.com/w550xh620/60a54c035feb3b00281478a9/igf-1r.png"},{"image":"https://icons.biorender.com/w75xh75/60a54c035feb3b00281478a8/igf-1r.png","waterMarkImage":"https://icons.biorender.com/w550xh620/60a54c035feb3b00281478a8/igf-1r.png"},{"image":"https://icons.biorender.com/w75xh75/60a54c035feb3b00281478a7/igf-1r.png","waterMarkImage":"https://icons.biorender.com/w550xh620/60a54c035feb3b00281478a7/igf-1r.png"},{"image":"https://icons.biorender.com/w75xh75/60a54c035feb3b00281478a6/igf-1r.png","waterMarkImage":"https://icons.biorender.com/w550xh620/60a54c035feb3b00281478a6/igf-1r.png"},{"image":"https://icons.biorender.com/w75xh75/60a54c035feb3b00281478a5/igf-1r.png","waterMarkImage":"https://icons.biorender.com/w550xh620/60a54c035feb3b00281478a5/igf-1r.png"},{"image":"https://icons.biorender.com/w75xh75/60a54c035feb3b00281478a4/igf-1r.png","waterMarkImage":"https://icons.biorender.com/w550xh620/60a54c035feb3b00281478a4/igf-1r.png"},{"image":"https://icons.biorender.com/w75xh75/60a54c035feb3b00281478a3/igf-1r.png","waterMarkImage":"https://icons.biorender.com/w550xh620/60a54c035feb3b00281478a3/igf-1r.png"},{"image":"https://icons.biorender.com/w75xh75/60a54c035feb3b00281478a2/igf-1r.png","waterMarkImage":"https://icons.biorender.com/w550xh620/60a54c035feb3b00281478a2/igf-1r.png"},{"image":"https://icons.biorender.com/w75xh75/60a54c035feb3b00281478a1/igf-1r.png","waterMarkImage":"https://icons.biorender.com/w550xh620/60a54c035feb3b00281478a1/igf-1r.png"},{"image":"https://icons.biorender.com/w75xh75/60a54c035feb3b00281478a0/igf-1r.png","waterMarkImage":"https://icons.biorender.com/w550xh620/60a54c035feb3b00281478a0/igf-1r.png"},{"image":"https://icons.biorender.com/w75xh75/60a54c035feb3b002814789f/igf-1r.png","waterMarkImage":"https://icons.biorender.com/w550xh620/60a54c035feb3b002814789f/igf-1r.png"},{"image":"https://icons.biorender.com/w75xh75/60a54c035feb3b002814789e/igf-1r.png","waterMarkImage":"https://icons.biorender.com/w550xh620/60a54c035feb3b002814789e/igf-1r.png"},{"image":"https://icons.biorender.com/w75xh75/60a54c035feb3b002814789d/igf-1r.png","waterMarkImage":"https://icons.biorender.com/w550xh620/60a54c035feb3b002814789d/igf-1r.png"},{"image":"https://icons.biorender.com/w75xh75/60a54c035feb3b002814789c/igf-1r.png","waterMarkImage":"https://icons.biorender.com/w550xh620/60a54c035feb3b002814789c/igf-1r.png"},{"image":"https://icons.biorender.com/w75xh75/60a54c035feb3b002814789b/igf-1r.png","waterMarkImage":"https://icons.biorender.com/w550xh620/60a54c035feb3b002814789b/igf-1r.png"},{"image":"https://icons.biorender.com/w75xh75/60a54c035feb3b002814789a/igf-1r.png","waterMarkImage":"https://icons.biorender.com/w550xh620/60a54c035feb3b002814789a/igf-1r.png"},{"image":"https://icons.biorender.com/w75xh75/60a54c035feb3b0028147899/igf-1r.png","waterMarkImage":"https://icons.biorender.com/w550xh620/60a54c035feb3b0028147899/igf-1r.png"},{"image":"https://icons.biorender.com/w75xh75/60a54c035feb3b0028147898/igf-1r.png","waterMarkImage":"https://icons.biorender.com/w550xh620/60a54c035feb3b0028147898/igf-1r.png"},{"image":"https://icons.biorender.com/w75xh75/60a54c035feb3b0028147897/igf-1r.png","waterMarkImage":"https://icons.biorender.com/w550xh620/60a54c035feb3b0028147897/igf-1r.png"},{"image":"https://icons.biorender.com/w75xh75/60a54c035feb3b0028147896/igf-1r.png","waterMarkImage":"https://icons.biorender.com/w550xh620/60a54c035feb3b0028147896/igf-1r.png"}]
Keywords
IGF-1R,insulin-like growth factor receptor,IGFR,CD221,IGFIR,JTK13, tyrosine kinase receptor,alpha unit, beta unit,monomer,transmembrane domain,cytoplasmic domain,ligand-binding,domain,extracellular,IGF1,IGF2,growth,anabolic, ,IGF-1R,IGF1R